Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 62

2.

Bone morphogenetic proteins in the development and healing of synovial joints.

Edwards CJ, Francis-West PH.

Semin Arthritis Rheum. 2001 Aug;31(1):33-42. Review.

PMID:
11503137
3.

Osteophytes: relevance and biology.

van der Kraan PM, van den Berg WB.

Osteoarthritis Cartilage. 2007 Mar;15(3):237-44. Epub 2007 Jan 3. Review.

4.

Growth factors and cartilage repair.

van den Berg WB, van der Kraan PM, Scharstuhl A, van Beuningen HM.

Clin Orthop Relat Res. 2001 Oct;(391 Suppl):S244-50. Review.

PMID:
11603708
5.

BMP/GDF-signalling interactions during synovial joint development.

Francis-West PH, Parish J, Lee K, Archer CW.

Cell Tissue Res. 1999 Apr;296(1):111-9. Review.

PMID:
10199971
6.

Regulation of osteogenic proteins by chondrocytes.

Chubinskaya S, Kuettner KE.

Int J Biochem Cell Biol. 2003 Sep;35(9):1323-40. Review.

PMID:
12798347
7.

Bone morphogenetic proteins in development.

Hogan BL.

Curr Opin Genet Dev. 1996 Aug;6(4):432-8. Review.

PMID:
8791534
8.

A role for age-related changes in TGFbeta signaling in aberrant chondrocyte differentiation and osteoarthritis.

van der Kraan PM, Blaney Davidson EN, van den Berg WB.

Arthritis Res Ther. 2010;12(1):201. doi: 10.1186/ar2896. Epub 2010 Jan 29. Review.

9.

Recent advances toward the clinical application of bone morphogenetic proteins in bone and cartilage repair.

Issack PS, DiCesare PE.

Am J Orthop (Belle Mead NJ). 2003 Sep;32(9):429-36. Review.

PMID:
14560824
10.

Bone morphogenetic protein and growth differentiation factor cytokine families and their protein antagonists.

Rider CC, Mulloy B.

Biochem J. 2010 Jul 1;429(1):1-12. doi: 10.1042/BJ20100305. Review.

PMID:
20545624
11.

Molecular biologic aspects of cartilage and bone: potential clinical applications.

Engstrand T.

Ups J Med Sci. 2003;108(1):25-35. Review.

PMID:
12903835
12.

Bone morphogenetic protein and bone morphogenetic protein gene family in bone formation and repair.

Wozney JM, Rosen V.

Clin Orthop Relat Res. 1998 Jan;(346):26-37. Review.

PMID:
9577407
13.

Bone morphogenetic proteins and bone morphogenetic protein gene therapy in neurological surgery: a review.

Helm GA, Alden TD, Sheehan JP, Kallmes D.

Neurosurgery. 2000 May;46(5):1213-22. Review.

PMID:
10807254
14.
15.

To seek shelter from the WNT in osteoarthritis? WNT-signaling as a target for osteoarthritis therapy.

Blom AB, van Lent PL, van der Kraan PM, van den Berg WB.

Curr Drug Targets. 2010 May;11(5):620-9. Review.

PMID:
20199388
16.

Osteoarthritis year 2010 in review: pathomechanisms.

van den Berg WB.

Osteoarthritis Cartilage. 2011 Apr;19(4):338-41. doi: 10.1016/j.joca.2011.01.022. Epub 2011 Feb 13. Review.

17.

Bone morphogenetic protein-7: an anti-fibrotic morphogenetic protein with therapeutic importance in renal disease.

Lund RJ, Davies MR, Hruska KA.

Curr Opin Nephrol Hypertens. 2002 Jan;11(1):31-6. Review.

PMID:
11753084
18.

Targeting TGFβ signaling in subchondral bone and articular cartilage homeostasis.

Zhen G, Cao X.

Trends Pharmacol Sci. 2014 May;35(5):227-36. doi: 10.1016/j.tips.2014.03.005. Epub 2014 Apr 15. Review.

19.

Organisation of bone morphogenetic proteins in renal development.

Martinez G, Bertram JF.

Nephron Exp Nephrol. 2003 Jan;93(1):e18-22. Review.

PMID:
12411745
20.

Antagonists of bone morphogenetic proteins in kidney disease.

Yanagita M.

Curr Opin Investig Drugs. 2010 Mar;11(3):315-22. Review.

PMID:
20178045
Items per page

Supplemental Content

Write to the Help Desk